Back to Search Start Over

Treatment of Chronic Bleeding From Gastric Antral Vascular Ectasia (GAVE) With Estrogen-Progesterone in Cirrhotic Patients: An Open Pilot Study.

Authors :
Tran, Albert
Villeneuve, Jean-Pierre
Bilodeau, Marc
Willems, Bernard
Marleau, Denis
Fenyves, Daphna
Parent, Roch
Pomier-Layrargues, Illes
Source :
American Journal of Gastroenterology (Springer Nature); Oct1999, Vol. 94 Issue 10, p2909-2911, 3p, 1 Chart, 1 Graph
Publication Year :
1999

Abstract

OBJECTIVE: Gastric antral vascular ectasia (GAVE) is a rare cause of chronic bleeding in cirrhotic patients. Treatment of GAVE with surgical or nonsurgical portal decompression, β-blockers, or endoscopic therapy provides disappointing results. In the present study, we evaluated the efficacy of estrogen-progesterone therapy, which has been reported to control chronic bleeding in gastrointestinal vascular malformations, such as Osler-Weber Rendu disease or angiodysplasia. in GAVE-related chronic bleeding. METHODS: Six cirrhotic patients who bled chronically from GAVE were included. Three had alcoholic cirrhosis, two cryptogenic cirrhosis, and one primary biliary cirrhosis. Grade I esophageal varices were noted in four patients. Bleeding could not be controlled by β-blockers, and endoscopic therapy was not considered given the extension of the antral vascular lesions. RESULTS: Before the start of therapy, transfusion requirements averaged 3.5 units/month over a 1.5-11 month period of observation. Patients were then treated with a combination of ethynil estradiol 30µg and noretisterone 1.5 mg daily. During follow-up (range 3-12 months), bleeding did not recur in four patients; in one patient, treatment with estrogen progesterone decreased the need for transfusions from 4 units/month to 1.4 unit/month: this patient stopped the treatment inadvertently after 6 months and severe anemia recurred with a need for 4 units of blood in the following month; reintroduction of the treatment resulted in an increase of hemoglobin levels without the need for blood transfusions during the following 4 months, ln the last patient, a 5-month treatment did not improve chronic bleeding. CONCLUSIONS: The present study suggests that estrogen-progesterone therapy is useful in the treatment of chronic bleeding related to GAVE; however, these findings require confirmation by a controlled trial. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00029270
Volume :
94
Issue :
10
Database :
Complementary Index
Journal :
American Journal of Gastroenterology (Springer Nature)
Publication Type :
Academic Journal
Accession number :
17665372
Full Text :
https://doi.org/10.1111/j.1572-0241.1999.01436.x